A Phase 1 Multiple-Dose, Open-Label, Pharmacokinetic Study of Nirmatrelvir/Ritonavir in Healthy Lactating Women.
Saved in:
| Title: | A Phase 1 Multiple-Dose, Open-Label, Pharmacokinetic Study of Nirmatrelvir/Ritonavir in Healthy Lactating Women. |
|---|---|
| Authors: | Gerhart J; Pfizer Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA., Cheruvu N; Pfizer Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA., Pelletier K; Pfizer Research and Development, Pfizer Inc, Groton, Connecticut, USA., Matschke K; Pfizer Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA., Shi H; Pfizer Research and Development, Pfizer Inc, Groton, Connecticut, USA., Mfopou JK; Pfizer Clinical Research Unit, Pfizer S.A./N.V., Brussels, Belgium., Hammond J; Pfizer Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA., Singh RSP; Pfizer Research and Development, Pfizer Inc, Cambridge, Massachusetts, USA. |
| Source: | Clinical and translational science [Clin Transl Sci] 2026 May; Vol. 19 (5), pp. e70552. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
